Try our mobile app

Dealings in securities by a prescribed officer of the company

Published: 2022-11-15 14:10:22 ET
<<<  go to JSE:ADH company page
ADvTECH Limited
(Incorporated in the Republic of South Africa)
(Registration number 1990/001119/06)
Share code: ADH            ISIN: ZAE000031035
(“ADvTECH” or “the Company”)


DEALINGS IN SECURITIES BY A PRESCRIBED OFFICER OF THE COMPANY


In terms of paragraphs 3.63 to 3.74 of the JSE Limited Listings Requirements (“JSE Listings
Requirements”), the following information relating to a Prescribed Officer’s dealings in the Company’s
securities is disclosed:


 Name of Prescribed Officer:                        DL Honey

 Designation:                                       Prescribed Officer

 Nature of transaction:                             Exercise of options which have vested in terms
                                                    of the ADvTECH Limited Share Incentive
                                                    Scheme (on market).
 Number of securities:                              41 100

 Date of Award                                      20 October 2016

 Class of securities:                               Ordinary

 Price of share:                                    R16.96

 Total value of transaction:                        R697 056.00

 Date of transaction:                               14 November 2022

 Volume weighted average price per share for

 the day:                                           R18.52

 Highest price on the date of the transaction:      R18.98

 Lowest price on the date of the transaction:       R18.21

 Nature of interest:                                Direct beneficial



 Name of Prescribed Officer:                        DL Honey
 Designation:                                       Prescribed Officer

 Nature of transaction:                             On-market sale of shares

 Number of securities:                              41 100

 Class of securities:                               Ordinary
 Price per share:                                  R18.50

 Total value:                                      R760 350.00

 Nature of interest:                               Direct beneficial

 Clearance to deal:                                Yes




15 November 2022
Johannesburg
Sponsor: Bridge Capital Advisors Proprietary Limited